GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Retained Earnings

Instadose Pharma (Instadose Pharma) Retained Earnings : $-135.89 Mil (As of Feb. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Instadose Pharma's retained earnings for the quarter that ended in Feb. 2022 was $-135.89 Mil.

Instadose Pharma's quarterly retained earnings declined from Aug. 2021 ($-0.22 Mil) to Nov. 2021 ($-0.58 Mil) and declined from Nov. 2021 ($-0.58 Mil) to Feb. 2022 ($-135.89 Mil).

Instadose Pharma's annual retained earnings declined from Nov. 2019 ($-0.08 Mil) to Nov. 2020 ($-0.11 Mil) and declined from Nov. 2020 ($-0.11 Mil) to Nov. 2021 ($-0.58 Mil).


Instadose Pharma Retained Earnings Historical Data

The historical data trend for Instadose Pharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Retained Earnings Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
Retained Earnings
Get a 7-Day Free Trial -0.03 -0.06 -0.08 -0.11 -0.58

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.17 -0.22 -0.58 -135.89

Instadose Pharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Instadose Pharma  (OTCPK:INSD) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus